Transmissible encephalopathies: Speculations and realities

Viral Immunology

Volumn 16, Issue 2, 2003, Pages 123-139

  Manuelidis, Laura ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; COMPLEMENTARY DNA; NUCLEIC ACID; PRION PROTEIN; RNA; VIRUS PROTEIN;

ANIMAL MODEL; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE COURSE; DISEASE TRANSMISSION; EPIDEMIC; HUMAN; IMMUNE SYSTEM; LATENT PERIOD; MOUSE; NONHUMAN; NUCLEIC ACID DATABASE; NUCLEOTIDE SEQUENCE; PRION DISEASE; REVIEW; SCRAPIE; SCRAPIE AGENT; SEQUENCE HOMOLOGY; STRAIN DIFFERENCE; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

ANIMALIA; MIRIDAE; SCRAPIE PRION;

EID: 0038719865     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282403322017875     Document Type: Review

References (54)

1. Aguzzi, A., and C. Weissmann. 1997. Prion research: the next frontiers. Nature 389:795-798.
2. Aiken, J.M., J.L. Williamson, M. Borchardt, et al. 1990. Presence of mitochondrial D-loop DNA in scrapie-infected brain preparations enriched for prion protein. J. Virol. 64:3265-3268.
3. Aucouturier, P., F. Geissmann, D. Damotte, et al. 2001. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. Clin. Invest. 703-708.
4. Baker, C., Z.Y. Lu, I. Zaitsev, et al. 1999. Microglial activation varies in different models of Creutzfeldt-Jakob disease. J. Virol. 73:5089-5097.
5. Baker, C., and L. Manuelidis. 2003. Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 100:675-679.
6. Baker, C.A., D. Martin, and L. Manuelidis. 2002. Microglia from CJD brain are infectious and show specific mRNA activation profiles. J. Virol. 10905-10913.
7. Barron, R., V. Thomson, E. Jamieson, et al. 2001. Changing a single amino acid in the N-terminus of murine PrP alters TSE incubation time across three species barriers. EMBO J. 17:5070-5078.
8. Bruce, M., A. Boyle, S. Cousens, et al. 2002. Strain characterization of natural sheep scrapie and comparison with BSE. J. Gen. Virol. 83:695-704.
9. Bruce, M.E., and A.G. Dickinson. 1987. Biological evidence that scrapie has an independent genome. J. Gen. Virol. 68:79-89.
10. Büeler, H., A. Aguzzi, A. Sailer, et al. 1993. Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347.
11. Carp, R., H. Meeker, and E. Sersen. 1997. Scrapie strains retain their distinctive characteristics following passages of homogenates from different brain regions and spleen. J. Gen. Virol. 78:283-290.
12. Diringer, H., M. Beekes, M. Ozel, et al. 1997. Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. Intervirology 40:238-246.
13. Diringer, H., H. Gelderblom, H. Hilmert, et al. 1983. Scrapie infectivity, fibrils and low molecular weight protein. Nature 306:476-478.
14. Dron, M., and L. Manuelidis. 1996. Visualization of viral candidate cDNAs in infectious brain fractions from Creutzfeldt-Jakob disease by representational difference analysis. J. Neurovirol. 2:240-248.
15. Eklund, C.M., R.C. Kennedy, and W.J. Hadlow. 1967. Pathogenesis of scrapie virus infection in the mouse. J. Infect. Dis. 117:15-22.
16. Fischer, M., T. Rulicke, A. Raeber, et al. 1996. Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J. 15:1255-1264.
17. Hegde, R., P. Tremblay, D. Groth, et al. 1999. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 402:822-826.
18. Hill, A., R. Butterworth, S. Joiner, et al. 1999. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183-189.
19. Houston, F., J. Foster, A. Chong, et al. 2000. Transmission of BSE by blood transfusion in sheep. Lancet 16:955-956.
20. Hunter, N., D. Cairns, J. Foster, et al. 1997. Is scrapie solely a genetic disease? Nature 386:137.
21. Lisitsyn, N., N. Lisitsyn, and M. Wigler. 1993. Cloning the differences between two complex genomes. Science 259:946-951.
22. Manuelidis, E.E., E.J. Gorgacz, and L. Manuelidis. 1978. Viremia in experimental Creutzfeldt-Jakob disease. Science 200:1069-1071.
23. Manuelidis, L. 1997. Beneath the emperor's clothes: the body of data in scrapie and CJD. Ann. Inst. Pasteur 8:311-326.
24. Manuelidis, L. 1997. Decontamination of Creutzfeldt-Jakob disease and other transmissible agents. J. Neurovirol. 3:62-65.
25. Manuelidis, L. 1994. Dementias, neurodegeneration, and viral mechanisms of disease from the perspective of human transmissible encephalopathies. Ann. N.Y. Acad. Sci. 724:259-281.
26. Manuelidis, L. 1994. The dimensions of Creutzfeldt-Jakob disease. Transfusion 34:915-928.
27. Manuelidis, L. 2000. Penny wise, pound foolish - a retrospective. Science 290:2257.
28. Manuelidis, L. 1998. Vaccination with an attenuated CJD strain prevents expression of a virulent agent. Proc. Natl. Acad. Sci. USA 95:2520-2525.
29. Manuelidis, L., and W. Fritch. 1996. Infectivity and host responses in Creutzfeldt-Jakob disease. Virology 215:46-59.
30. Manuelidis, L., W. Fritch, and Y.G. Xi. 1997. Evolution of a strain of CJD that induces BSE-like plaques. Science 277:94-98.
31. Manuelidis, L., and Z.Y. Lu. 2000. Attenuated Creutzfeldt-Jakob disease agents can hide more virulent infections. Neurosci. Lett. 293:163-166.
32. a. Manuelidis, L., and B.Y. Lu. 2003. Virus-like interference in the latency and prevention of Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 100:5360-5365.
33. Manuelidis, L., G. Murdoch, and E. Manuelidis. 1988. Potential involvement of retroviral elements in human dementias. Ciba Found. Symp. 135:117-134.
34. Manuelidis, L., T. Sklaviadis, A. Akowitz, et al. 1995. Viral particles are required for infection in neurodegenerative Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 92:5124-5128.
35. Manuelidis, L., T. Sklaviadis, and E.E. Manuelidis. 1987. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease. EMBO J. 6:341-347.
36. Manuelidis, L., I. Zaitsev, P. Koni, et al. 2000. Follicular dendritic cells and the dissemination of Creutzfeldt-Jakob disease. J. Virol. 74:8614-8622.
37. McKinley, M.P., D.C. Bolton, and S.B. Prusiner. 1983. A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57-62.
38. Merz, P.A., R.A. Somerville, H.M. Wisniewski, et al. 1983. Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature 306:474-476.
39. Montrasio, F., R. Frigg, M. Glatzel, et al. 2000. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288:1257-1259.
40. Murdoch, G., T. Sklaviadis, E.E. Manuelidis, et al. 1990. Potential retroviral RNAs in Creutzfeldt-Jakob disease. J. Virol. 64:1477-1486.
41. Nishida, N., D.A. Harris, D. Vilette, et al. 2000. Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J. Virol. 74:320-325.
42. Oesch, B., D.F. Groth, S.B. Prusiner, et al. 1988. Search for a scrapie-specific nucleic acid: a progress report. Ciba Found. Symp. 135:209-217.
43. Prusiner, S., M. Baldwin, J. Collinge, et al. 1995. Prions. Springer Verlag, Wien.
44. Prusiner, S.B. 1991. Molecular biology of prion diseases. Science 252:1515-1522.
45. Radebold, K., M. Chernyak, D. Martin, et al. 2001. Blood-borne transit of CJD from brain to gut at early stages of infection. BMC Infect. Dis. 1:20-25.
46. Riesner, D., K. Kellings, K. Post, et al. 1996. Disruption of prion rods generates 10-nm spherical particles having high a-helical content and lacking scrapie infectivity. J. Virol. 70:1714-1722.
47. Saborio, G., B. Permanne, and C. Soto. 2001. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411:810-813.
48. Shaked, G., Z. Meiner, I. Avraham, et al. 2001. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods. J. Biol. Chem. 17:1432-1438.
49. Shlomchik, M., K. Radebold, N. Duclos, et al. 2001. Neuroinvasion by a Creutzfeldt-Jakob disease agent in the absence of B cells and follicular dendritic cells. Proc. Natl. Acad. Sci. USA 98:9289-9294.
50. Sklaviadis, T., A. Akowitz, E.E. Manuelidis, et al. 1990. Nuclease treatment results in high specific purification of Creutzfeldt-Jakob disease infectivity with a density characteristic of nucleic acid-protein complexes. Arch. Virol. 112:215-229.
51. Somerville, R.A., and A. Dunn, 1996. The association between PrP and infectivity in scrapie and BSE infected mouse brain. Arch Virol. 14:275-289.
52. Tateishi, J., P. Brown, T. Kitamoto, et al. 1995. First experimental transmission of fatal familial insomnia. Nature 376:434-435.
53. Telling, G.C., M. Scott, J. Mastrianni, et al. 1995. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83:79-90.
54. Xi, Y.G., A. Ingrosso, A. Ladogana, et al. 1992. Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356:598-601.